AARD - Aardvark Therapeutics, Inc.
3.55
0.040 1.127%
Share volume: 225,153
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$3.51
0.04
0.01%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2025 | 11-13-2025 | 03-23-2026 | |
| Assets | ||||
| Total Assets | 157.025 M | 133.229 M | 117.181 M | |
| Current Assets | 154.554 M | 129.207 M | 111.886 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 124.756 M | 87.065 M | 62.976 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 26.504 M | 39.285 M | 47.051 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | |
| Other Assets | 2.471 M | 4.022 M | 5.295 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 157.025 M | 133.229 M | 117.181 M | |
| Total liabilities | 6.336 M | 10.852 M | 10.548 M | |
| Total current liabilities | 5.976 M | 10.736 M | 10.548 M | |
| Accounts Payable | 2.556 M | 4.444 M | 2.072 M | |
| Other liabilities | 360.000 K | 116.000 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 360.000 K | 116.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 150.689 M | 122.377 M | 106.633 M | |
| Common stock | 218.282 M | 220.615 M | 222.470 M | |
| Retained earnings | -67.637 M | -98.320 M | -115.918 M |